<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03827733</url>
  </required_header>
  <id_info>
    <org_study_id>dsyy004</org_study_id>
    <nct_id>NCT03827733</nct_id>
  </id_info>
  <brief_title>Gut Microbiota and Alzheimer's Diseases</brief_title>
  <official_title>Gut Microbiota and Alzheimer's Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator will perform clinical studies to test a hypothesis that participants who&#xD;
      have Alzheimer's disease will have different gut/oral microbiota profile as compared to the&#xD;
      participants who do not have Alzheimer's disease. The investigators will also check the&#xD;
      microbiome of their partners in this study. The investigators plan to perform the studies in&#xD;
      150 participants in Shanghai Tenth's People's Hospital and also in the houses in Shanghai&#xD;
      city. Investigators will also measure the beta-amyloid in the feces of the participants.&#xD;
      Finally, the investigators will determine cognitive function in these participants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies have shown that gut/oral microbiome and beta-amyloid in body may have a significant&#xD;
      impact on the behavior and brain pathology consistent with Alzheimer's disease (AD)&#xD;
      neuropathogenesis. The objective of this study is to assess whether the gut/oral microbiome&#xD;
      and feces beta-amyloid of AD patients are different from those of the participants without AD&#xD;
      and their partners. The investigators plan to recruit 150 subjects, including three groups of&#xD;
      normal elders, AD patients and the partners of the AD patients. The cognitive function will&#xD;
      be assessed and the feces and oral samples will be collected to determine whether there are&#xD;
      differences or correlations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gut beta-amyloid 42</measure>
    <time_frame>Through study completion, an average of 4 year</time_frame>
    <description>Gut amyloid-beta 42 will be determined by digital ELISA, traditional ELISA and western blot.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut microbiota</measure>
    <time_frame>Through study completion, an average of 4 year</time_frame>
    <description>We will use DNA sequencing to define the profile of gut microbiota.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral microbiota</measure>
    <time_frame>Through study completion, an average of 4 year</time_frame>
    <description>We will use DNA sequencing to define the profile of gut microbiota.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function by Mini-mental State Examination (MMSE)</measure>
    <time_frame>through study completion, an average of 4 year</time_frame>
    <description>We will assess the cognitive function in the participants using MMSE to promote the diagnosis of AD in these participants. The sum of MMSE ranges from 0 (worse) to 30 (better).</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>AD patients</arm_group_label>
    <description>Participants who are diagnosed with AD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Partners of the AD patients</arm_group_label>
    <description>Partners of AD patients who live together with the AD patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Elderly participants with normal cognition</arm_group_label>
    <description>Community dwelling elderly with normal cognition and with AD.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fecal sample collection&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Elderly participants with normal congition will be collected from community. Alzheimer's&#xD;
        disease participants and their spouse will be collected from Shanghai Tenth People's&#xD;
        Hopital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged 60 and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  with other acute gastrointestinal diseases&#xD;
&#xD;
          -  with other severe neuropsychiatric disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuan Shen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai 10th People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuan Shen, MD, PhD</last_name>
    <phone>02166303649</phone>
    <email>kmshy@tongji.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhongyong Shi, MD</last_name>
    <phone>18701915271</phone>
    <email>szy0721@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Tenth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanxia Guo, M.D.</last_name>
      <phone>021-65982875</phone>
      <email>guoyx_2000@tongji.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 28, 2018</study_first_submitted>
  <study_first_submitted_qc>January 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2019</study_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Yuan Shen, MD, PhD</investigator_full_name>
    <investigator_title>Chief of Psychiatry Department</investigator_title>
  </responsible_party>
  <keyword>Gut Microbiota</keyword>
  <keyword>Alzheimer's Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

